Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227838
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2005-09-27
Brief Title:
Modifying Group Therapy for Bipolar Substance Abusers - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Modifying Group Therapy for Bipolar Abusers
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to modify Integrated Group Therapy IGT which is has been found successful for patients with bipolar disorder BD and substance use disorderSUD so that it can be more readily adopted by community drug abuse treatment programs IGT is being reduced from 20 to 12 sessions in this trial and is being conducted by front-line drug counselors to test its effectiveness in a more community-based setting The training has been expanded so that counselors without much psychopathology training or cognitive behavioral therapy experience can conduct IGT
Detailed Description:
IGT is being compared with 12 sessions of Group Drug Counseling GDC in a randomized controlled trial with a sample size of 60 subjects GDC is the type of treatment one would likely receive in a community drug abuse treatment program in that it focuses primarily in substance use unlike IGT which focuses equally on SUD and BD issues Patients are followed for a year after the end of the group therapy to examine the long-term effects of the treatment and also to examine the longer-term relationship of substance use and mood Patients in the trial must be taking a mood stabilizer to enter the study Any drug of abuse is accepted and all subtypes of BD are accepted
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-15968-1 | None | None | None |